192 related articles for article (PubMed ID: 9205036)
1. The rule of 5 and the rule of 7 in lipid-lowering by statin drugs.
Roberts WC
Am J Cardiol; 1997 Jul; 80(1):106-7. PubMed ID: 9205036
[No Abstract] [Full Text] [Related]
2. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
Pincus J
Am J Cardiol; 1998 Aug; 82(3):406-7. PubMed ID: 9708683
[No Abstract] [Full Text] [Related]
3. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
Jones P; Kafonek S; Laurora I; Hunninghake D
Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454
[TBL] [Abstract][Full Text] [Related]
4. Managed care trends in statin usage.
Bazalo GR
Manag Care; 2001 Oct; 10(10):48-50, 53-9. PubMed ID: 11688111
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of atorvastatin in heart transplant recipients.
Patel DN; Pagani FD; Koelling TM; Dyke DB; Baliga RR; Cody RJ; Lake KD; Aaronson KD
J Heart Lung Transplant; 2002 Feb; 21(2):204-10. PubMed ID: 11834348
[TBL] [Abstract][Full Text] [Related]
6. By the way, doctor... My brother takes Mevacor and has been told to take the drug at bedtime. But when I started on Lipitor, my doctor said to take the medication at any time of the day. Why the difference?
Lee TH
Harv Health Lett; 2001 Aug; 26(10):8. PubMed ID: 11546623
[No Abstract] [Full Text] [Related]
7. Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients.
Asztalos BF; Horvath KV; McNamara JR; Roheim PS; Rubinstein JJ; Schaefer EJ
Atherosclerosis; 2002 Oct; 164(2):361-9. PubMed ID: 12204809
[TBL] [Abstract][Full Text] [Related]
8. The HMG Co-A reductase inhibitors ('statins') and myotoxic effects.
S Afr Med J; 2002 Aug; 92(8):596-7. PubMed ID: 12244613
[No Abstract] [Full Text] [Related]
9. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
van der Harst P; Voors AA; van Veldhuisen DJ
N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15306676
[No Abstract] [Full Text] [Related]
10. [Which statin is more efficient? Concepts and applications in economic evaluation].
García-Altés A; Jovell AJ
Aten Primaria; 2000 Sep; 26(5):333-8. PubMed ID: 11100606
[No Abstract] [Full Text] [Related]
11. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
Gotto AM
N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309745
[No Abstract] [Full Text] [Related]
12. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
Paradis JM; LeLorier J
N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309744
[No Abstract] [Full Text] [Related]
13. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
Miller M
N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309746
[No Abstract] [Full Text] [Related]
14. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
Auer J; Weber T; Eber B
N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309747
[No Abstract] [Full Text] [Related]
15. Statins and prostate cancer diagnosis and grade in a veterans population.
Farwell WR; D'Avolio LW; Scranton RE; Lawler EV; Gaziano JM
J Natl Cancer Inst; 2011 Jun; 103(11):885-92. PubMed ID: 21498780
[TBL] [Abstract][Full Text] [Related]
16. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
17. New statins and new doses of older statins.
Stein EA
Curr Atheroscler Rep; 2001 Jan; 3(1):14-8. PubMed ID: 11123843
[TBL] [Abstract][Full Text] [Related]
18. High-intensity statin treatment for coronary heart disease.
Sacks FM
JAMA; 2004 Mar; 291(9):1132-4. PubMed ID: 14996784
[No Abstract] [Full Text] [Related]
19. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
Jacobson TA
Am J Cardiol; 2004 Nov; 94(9):1140-6. PubMed ID: 15518608
[TBL] [Abstract][Full Text] [Related]
20. Fluvastatin versus pravastatin.
Chilton R
Am J Cardiol; 1996 Jul; 78(1):127. PubMed ID: 8712106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
